ALLC (NM_018436) Human Recombinant Protein
CAT#: TP316471
Recombinant protein of human allantoicase (ALLC), transcript variant 1
Specifications
Product Data | |
Species | Human |
Expression Host | HEK293T |
Expression cDNA Clone or AA Sequence |
Recombinant protein was produced with TrueORF clone, RC216471. Click on the TrueORF clone link to view cDNA and protein sequences.
|
Tag | C-Myc/DDK |
Predicted MW | 43.4 kDa |
Concentration | >50 ug/mL as determined by microplate BCA method |
Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Buffer | 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol |
Preparation | Recombinant protein was captured through anti-DDK affinity column followed by conventional chromatography steps. |
Storage | Store at -80°C. |
Stability | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Reference Data | |
RefSeq | NP_060906 |
Locus ID | 55821 |
UniProt ID | Q8N6M5 |
Cytogenetics | 2p25.3 |
Refseq Size | 1443 |
Refseq ORF | 1173 |
Synonyms | ALC |
Summary | Allantoicase (EC 3.5.3.4) participates in the uric acid degradation pathway. Its enzymatic activity, like that of urate oxidase (MIM 191540), was lost during vertebrate evolution. [supplied by OMIM, Nov 2008] |
Protein Pathways | Metabolic pathways, Purine metabolism |
Documents
FAQs |
SDS |
Resources
Recombinant Protein Resources |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
LC413022 | ALLC HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LY413022 | Transient overexpression lysate of allantoicase (ALLC), transcript variant 1 |
USD 396.00 |
|
PH316471 | ALLC MS Standard C13 and N15-labeled recombinant protein (NP_060906) |
USD 2,055.00 |
{0} Product Review(s)
Be the first one to submit a review